This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A multicenter, open label, randomized phase III study of atezolizumab with platinum-pemetrexed and with or without bevacizumab for patients with advanced nonsquamous non-small cell lung cancer (WJOG11218L APPLE Study)., Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2019.37.15_suppl.tps9125.
You can read the full text:
The following have contributed to this page
